Chemed vs Hims & Hers Health
Chemed and Hims & Hers Health are similar in size: $2.53bn and $2.35bn of revenue in their latest fiscal years. Hims & Hers Health grew faster (59.0% against 4.1%). Chemed kept more of each dollar of sales as profit: a net margin of 10.5% against 5.5%. Chemed carries less debt relative to equity (0.0% against 179.8%).
| Latest fiscal year | ChemedCHE, 2025 | Hims & Hers HealthHIMS, 2025 |
|---|---|---|
| Revenue | $2.53bn | $2.35bn |
| Revenue growth | 4.1% | 59.0% |
| Net income | $265m | $128m |
| Operating margin | 13.4% | 4.5% |
| Net margin | 10.5% | 5.5% |
| Return on equity | 25.3% | 25.2% |
| Free cash flow | $325m | $57.4m |
| Cash | $74.5m | $229m |
| Total debt | $0 | $973m |
| Debt to equity | 0.0% | 179.8% |
| Dividend per share | $2.20 | — |
| Dividend yield | 0.5% | — |
| Share buybacks | $432m | $90.0m |
| Employees | 15,811 | — |
| Market value | $7.03bn | $5.93bn |
| Price vs our value range | Within our value range | — |
| Moat score | 68 (Moderate) | 33 (Weak) |
| Insider trades, 12 months | 0 buys, 13 sales | 1 buys, 46 sales |